{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:21:24Z","timestamp":1788193284513,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-026-00649-3","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:10:16Z","timestamp":1788192616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient knowledge and medication safety in chronic warfarin therapy: the roles of adherence, diet, and drug\u2013drug interactions"],"prefix":"10.1007","volume":"34","author":[{"given":"Ahmet","family":"\u00c7ak\u0131r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melisa Sultan","family":"Tek\u015fahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7158-1795","authenticated-orcid":false,"given":"Hasan","family":"Memi\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Cansel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"issue":"8","key":"649_CR1","first-page":"1661","volume":"13","author":"AJ Vega","year":"2023","unstructured":"Vega AJ, Smith C, Matejowsky HG, Thornhill KJ, Borne GE, Mosieri CN, Shekoohi S, Cornett EM, Kaye AD. Warfarin and Antibiotics: drug interactions and clinical considerations. Life (Basel). 2023;13(8):1661.","journal-title":"Life (Basel)"},{"key":"649_CR2","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1160\/TH14-10-0859","volume":"6","author":"V Sj\u00f6gren","year":"2015","unstructured":"Sj\u00f6gren V, Grzymala-Lubanski B, Renlund H, Friberg L, Lip GY, Svensson PJ, Sj\u00e4lander A. Safety and efficacy of well managed warfarin. A report from the Swedish quality register Auricula. Thromb Haemost. 2015;6:1370\u20137.","journal-title":"Thromb Haemost"},{"key":"649_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00228-019-02772-4","volume":"2","author":"MFS Praxedes","year":"2020","unstructured":"Praxedes MFS, Martins MAP, Mour\u00e3o AOM, Gomes KB, Reis EA, Souza RP, Campos EIF, Ribeiro DD, Rocha MOC. Non-genetic factors and polymorphisms in genes CYP2C9 and VKORC1: predictive algorithms for TTR in Brazilian patients on warfarin. Eur J Clin Pharmacol. 2020;2:199\u2013209.","journal-title":"Eur J Clin Pharmacol"},{"key":"649_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/pds.3769","volume":"6","author":"JA Roth","year":"2015","unstructured":"Roth JA, Bradley K, Thummel KE, Veenstra DL, Boudreau D. Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting. Pharmacoepidemiol Drug Saf. 2015;6:619\u201327.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"649_CR5","doi-asserted-by":"publisher","first-page":"23463","DOI":"10.1038\/s41598-025-08229-2","volume":"1","author":"P Sae-Lim","year":"2025","unstructured":"Sae-Lim P, Saelue P. Appropriate target range of INR and predictive factors of recurrent thrombosis and bleeding in patients with venous thromboembolism on warfarin. Sci Rep. 2025;1:23463.","journal-title":"Sci Rep"},{"key":"649_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1538-7836.2010.03756.x","volume":"4","author":"DM Witt","year":"2010","unstructured":"Witt DM, Delate T, Clark NP, Martell C, Tran T, Crowther MA, Garcia DA, Ageno W, Hylek EM. Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users. J Thromb Haemost. 2010;4:744\u20139.","journal-title":"J Thromb Haemost"},{"key":"649_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jsps.2015.02.005","volume":"1","author":"AY Mayet","year":"2016","unstructured":"Mayet AY. Patient adherence to warfarin therapy and its impact on anticoagulation control. Saudi Pharm J. 2016;1:29\u201334.","journal-title":"Saudi Pharm J"},{"key":"649_CR8","first-page":"294","volume":"4","author":"ASM Lam","year":"2020","unstructured":"Lam ASM, Lee IMH, Mak SKS, Yan BPY, Lee VWY. Warfarin control in Hong Kong clinical practice: a single-centre observational study. Hong Kong Med J. 2020;4:294\u2013303.","journal-title":"Hong Kong Med J"},{"key":"649_CR9","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.thromres.2014.01.013","volume":"4","author":"RS Cancino","year":"2014","unstructured":"Cancino RS, Hylek EM, Reisman JI, Rose AJ. Comparing patient-level and site-level anticoagulation control as predictors of adverse events. Thromb Res. 2014;4:652\u20136.","journal-title":"Thromb Res"},{"key":"649_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1001\/archinte.167.3.239","volume":"3","author":"HD White","year":"2007","unstructured":"White HD, Gruber M, Feyzi J, Kaatz S, Tse HF, Husted S, Albers GW. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med. 2007;3:239\u201345.","journal-title":"Arch Intern Med"},{"key":"649_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1177\/10998004221127977","volume":"1","author":"S Turen","year":"2023","unstructured":"Turen S, Turen S. Determination of Factors Affecting Time in Therapeutic Range in Patients on Warfarin Therapy. Biol Res Nurs. 2023;1:170\u20138.","journal-title":"Biol Res Nurs"},{"key":"649_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.thromres.2014.01.002","volume":"4","author":"Y Wang","year":"2014","unstructured":"Wang Y, Kong MC, Lee LH, Ng HJ, Ko Y. Knowledge, satisfaction, and concerns regarding warfarin therapy and their association with warfarin adherence and anticoagulation control. Thromb Res. 2014;4:550\u20134.","journal-title":"Thromb Res"},{"key":"649_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.biopha.2016.06.012","volume":"83","author":"PM Leite","year":"2016","unstructured":"Leite PM, Martins MAP, Castilho RO. Review on mechanisms and interactions in concomitant use of herbs and warfarin therapy. Biomed Pharmacother. 2016;83:14\u201321.","journal-title":"Biomed Pharmacother"},{"key":"649_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/bcp.14404","volume":"2","author":"CSS Tan","year":"2021","unstructured":"Tan CSS, Lee SWH. Warfarin and food, herbal or dietary supplement interactions: A systematic review. Br J Clin Pharmacol. 2021;2:352\u201374.","journal-title":"Br J Clin Pharmacol"},{"key":"649_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1472-6963-8-40","volume":"8","author":"JL Wofford","year":"2008","unstructured":"Wofford JL, Wells MD, Singh S. Best strategies for patient education about anticoagulation with warfarin: a systematic review. BMC Health Serv Res. 2008;8:40.","journal-title":"BMC Health Serv Res"},{"key":"649_CR16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1345\/aph.1G562","volume":"4","author":"MM Zeolla","year":"2006","unstructured":"Zeolla MM, Brodeur MR, Dominelli A, Haines ST, Allie ND. Development and validation of an instrument to determine patient knowledge: the oral anticoagulation knowledge test. Ann Pharmacother. 2006;4:633\u20138.","journal-title":"Ann Pharmacother"},{"key":"649_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4274\/tjps.galenos.2020.88319","volume":"4","author":"M T\u00fcrker","year":"2021","unstructured":"T\u00fcrker M, Sancar M, Demirtun\u00e7 R, U\u00e7ar N, Uzman O, Ay P, Kozan \u00d6, Okuyan B. Validation of a Knowledge Test in Turkish Patients on Warfarin Therapy at an Ambulatory Anticoagulation Clinic. Turk J Pharm Sci. 2021;4:445\u201351.","journal-title":"Turk J Pharm Sci"},{"key":"649_CR18","doi-asserted-by":"publisher","first-page":"815","DOI":"10.30621\/jbachs.1032020","volume":"3","author":"EA Kankaya","year":"2022","unstructured":"Kankaya EA, Bilik \u00d6. Development of an adherence to anticoagulant therapy scale: A validity and reliability study. J Basic Clin Health Sci. 2022;3:815\u201323.","journal-title":"J Basic Clin Health Sci"},{"key":"649_CR19","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"19","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, Grams ME, Greene T, Grubb A, Gudnason V, Guti\u00e9rrez OM, Kalil R, Karger AB, Mauer M, Navis G, Nelson RG, Poggio ED, Rodby R, Rossing P, Rule AD, Selvin E, Seegmiller JC, Shlipak MG, Torres VE, Yang W, Ballew SH, Couture SJ, Powe NR, Levey AS. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;19:1737\u201349.","journal-title":"N Engl J Med"},{"key":"649_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","volume":"4","author":"MC Fang","year":"2011","unstructured":"Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011;4:395\u2013401.","journal-title":"J Am Coll Cardiol"},{"key":"649_CR21","first-page":"236","volume":"3","author":"FR Rosendaal","year":"1993","unstructured":"Rosendaal FR, Cannegieter SC, van der Meer FJ, Bri\u00ebt E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;3:236\u20139.","journal-title":"Thromb Haemost"},{"key":"649_CR22","doi-asserted-by":"crossref","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. routledge; 2013.","DOI":"10.4324\/9780203771587"},{"key":"649_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.5603\/CJ.a2015.0035","volume":"5","author":"UO Turk","year":"2015","unstructured":"Turk UO, Tuncer E, Alioglu E, Yuksel K, Pekel N, Ozpelit E, Vuran O, Tengiz I. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry. Cardiol J. 2015;5:567\u201375.","journal-title":"Cardiol J"},{"issue":"10","key":"649_CR24","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.3390\/ijerph18105214","volume":"18","author":"S Park","year":"2021","unstructured":"Park S, Jang I. Factors affecting medication adherence in patients with Mechanical Heart Valves Taking Warfarin: the role of knowledge on warfarin, medication belief, depression, and self-efficacy. Int J Environ Res Public Health. 2021;18(10):5214.","journal-title":"Int J Environ Res Public Health"},{"key":"649_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000511754","volume":"5\u20136","author":"H Ahmed","year":"2021","unstructured":"Ahmed H, Saddouh EA, Abugrin ME, Ali AMM, Elgdhafi EO, Khaled A, Tarek A, Elhadi M. Association between Patients\u2019 Knowledge and Adherence to Anticoagulants, and Its Effect on Coagulation Control. Pharmacology. 2021;5\u20136:265\u201374.","journal-title":"Pharmacology"},{"key":"649_CR26","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s11096-016-0282-9","volume":"4","author":"MA Ababneh","year":"2016","unstructured":"Ababneh MA, Al-Azzam SI, Alzoubi KH, Rababa\u2019h AM. Adherence in outpatients taking warfarin and its effect on anticoagulation control in Jordan. Int J Clin Pharm. 2016;4:816\u201321.","journal-title":"Int J Clin Pharm"},{"key":"649_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11096-017-0569-5","volume":"1","author":"SAR Shilbayeh","year":"2018","unstructured":"Shilbayeh SAR, Almutairi WA, Alyahya SA, Alshammari NH, Shaheen E, Adam A. Validation of knowledge and adherence assessment tools among patients on warfarin therapy in a Saudi hospital anticoagulant clinic. Int J Clin Pharm. 2018;1:56\u201366.","journal-title":"Int J Clin Pharm"},{"key":"649_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13104-025-07167-6","volume":"1","author":"N Kokash","year":"2025","unstructured":"Kokash N, Gharaibeh L, Al Zoubi S. Association between knowledge of anticoagulation, INR control, and warfarin-related adverse events: a cross sectional study. BMC Res Notes. 2025;1:98.","journal-title":"BMC Res Notes"},{"key":"649_CR29","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.2147\/PPA.S172223","volume":"12","author":"X Wang","year":"2018","unstructured":"Wang X, Xu B, Liang H, Jiang S, Tan H, Wang X, Wang X, Yu S, Liu J. Distribution characteristics and factors influencing oral warfarin adherence in patients after heart valve replacement. Patient Prefer Adherence. 2018;12:1641\u20138.","journal-title":"Patient Prefer Adherence"},{"key":"649_CR30","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s11096-020-01043-y","volume":"3","author":"H Cao","year":"2020","unstructured":"Cao H, Wu T, Chen W, Fu J, Xia X, Zhang J. The effect of warfarin knowledge on anticoagulation control among patients with heart valve replacement. Int J Clin Pharm. 2020;3:861\u201370.","journal-title":"Int J Clin Pharm"},{"key":"649_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jsps.2017.11.010","volume":"1","author":"B Balkhi","year":"2018","unstructured":"Balkhi B, Al-Rasheedi M, Elbur AI, Alghamadi A. Association between satisfaction with and adherence to warfarin therapy on the control of international normalized ratio: A hospital-based study in Saudi Arabia. Saudi Pharm J. 2018;1:145\u20139.","journal-title":"Saudi Pharm J"},{"key":"649_CR32","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1111\/bcp.14833","volume":"11","author":"M Wang","year":"2021","unstructured":"Wang M, Zeraatkar D, Obeda M, Lee M, Garcia C, Nguyen L, Agarwal A, Al-Shalabi F, Benipal H, Ahmad A, Abbas M, Vidug K, Holbrook A. Drug-drug interactions with warfarin: A systematic review and meta-analysis. Br J Clin Pharmacol. 2021;11:4051\u2013100.","journal-title":"Br J Clin Pharmacol"},{"key":"649_CR33","first-page":"520","volume":"2","author":"H Memi\u015f","year":"2023","unstructured":"Memi\u015f H, \u00c7ak\u0131r A, \u00d6zdemir N, G\u00fcn Z\u00dc. Determination of potential drug-drug interactions in general pediatric ward patients: a cross-sectional study. J Fac Pharm Ankara Univ. 2023;2:520\u201330.","journal-title":"J Fac Pharm Ankara Univ"},{"key":"649_CR34","doi-asserted-by":"publisher","first-page":"2515690X2513344","DOI":"10.1177\/2515690X251334445","volume":"30","author":"LJ Uribe-Cavero","year":"2025","unstructured":"Uribe-Cavero LJ, Vera-Maccha PJ, Siguas-Huasasquiche A, Bohorquez-Espino EE, Taype-Rondan A. Inconsistent reporting of interactions between warfarin and medicinal plants across clinical decision support resources. J Evid Based Integr Med. 2025;30:2515690X251334445.","journal-title":"J Evid Based Integr Med"},{"key":"649_CR35","first-page":"8","volume":"1","author":"K Methaset","year":"2026","unstructured":"Methaset K, Jedsadayanmata A. Burden and Determinants of Drug\u2013Drug Interactions at Hospital Discharge: Warfarin as a Model for High-Risk Medication Safety. Clin Pract. 2026;1:8.","journal-title":"Clin Pract"},{"key":"649_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11606-014-2993-8","volume":"1","author":"W Leiss","year":"2015","unstructured":"Leiss W, M\u00e9an M, Limacher A, Righini M, Jaeger K, Beer HJ, Osterwalder J, Frauchiger B, Matter CM, Kucher N, Angelillo-Scherrer A, Cornuz J, Banyai M, L\u00e4mmle B, Husmann M, Egloff M, Aschwanden M, Rodondi N, Aujesky D. Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism. J Gen Intern Med. 2015;1:17\u201324.","journal-title":"J Gen Intern Med"},{"key":"649_CR37","doi-asserted-by":"publisher","first-page":"100020","DOI":"10.1016\/j.crphar.2021.100020","volume":"2","author":"B Papotti","year":"2021","unstructured":"Papotti B, Marchi C, Adorni MP, Pot\u00ec F. Drug-drug interactions in polypharmacy patients: The impact of renal impairment. Curr Res Pharmacol Drug Discov. 2021;2:100020.","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"649_CR38","first-page":"141","volume":"1","author":"D Feldeisen","year":"2023","unstructured":"Feldeisen D, Alexandris-Souphis C, Haymart B, Gu X, Perry L, Watts S, Kozlowski R, Kozlowski J, Froehlich JB, Barnes GD, Kline-Rogers E. Higher OAK (Oral Anticoagulation Knowledge) score at baseline associated with better TTR (Time in Therapeutic Range) in patients taking warfarin. J Thromb Thrombolysis. 2023;1:141\u20138.","journal-title":"J Thromb Thrombolysis"},{"key":"649_CR39","first-page":"e20220158","volume":"36","author":"MS Marcolino","year":"2023","unstructured":"Marcolino MS, Sales TLS, Oliveira JAd, Rios DRA, Pedroso TM, S\u00e1 LCd, Martins MA, Ribeiro ALP. Health literacy, patient knowledge and adherence to oral anticoagulation in primary care. Int J Cardiovasc Sci. 2023;36:e20220158.","journal-title":"Int J Cardiovasc Sci"},{"key":"649_CR40","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s11239-020-02280-8","volume":"4","author":"L Marcatto","year":"2021","unstructured":"Marcatto L, Boer B, Sacilotto L, Olivetti N, Darrieux FCC, Scanavacca MI, Pereira AC, Santos P. Impact of adherence to warfarin therapy during 12 weeks of pharmaceutical care in patients with poor time in the therapeutic range. J Thromb Thrombolysis. 2021;4:1043\u20139.","journal-title":"J Thromb Thrombolysis"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00649-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-026-00649-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00649-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:10:18Z","timestamp":1788192618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-026-00649-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["649"],"URL":"https:\/\/doi.org\/10.1007\/s40199-026-00649-3","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from all participants prior to inclusion in the study.","order":1,"name":"Ethics","label":"<b>Consent to participate<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided informed consent for the use of anonymized data for research purposes.","order":2,"name":"Ethics","label":"<b>Consent to publish<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"66"}}